Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 36.66% is 15% below its 5-year average of 43.34%, around the middle of its 5-year range (-48.61%–97.07%).
87.14% above its 12-month average of 19.59%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 42.52%.
OPERATING MARGIN
36.66%
OPERATING MARGIN AVG TTM
19.59%
OPERATING MARGIN AVG 3Y
39.82%
OPERATING MARGIN AVG 5Y
43.34%
OPERATING MARGIN AVG 10Y
71.22%
OPERATING MARGIN AVG 15Y
62.94%
OPERATING MARGIN AVG 20Y
-161.59%
CURRENT VS TTM AVG
+87.14%
CURRENT VS 3Y AVG
-7.94%
CURRENT VS 5Y AVG
-15.42%
CURRENT VS 10Y AVG
-48.53%
CURRENT VS 15Y AVG
-41.75%
CURRENT VS 20Y AVG
+122.69%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Innoviva, Inc.
Market Cap
$1.54B
Operating Margin
36.66%
TTM Avg
19.59%
3Y Avg
39.82%
5Y Avg
43.34%
Market Cap
$1.53B
Operating Margin
-158.45%
TTM Avg
-796.44%
3Y Avg
-398.22%
5Y Avg
-1047.05%
Market Cap
$1.55B
Operating Margin
-11.16%
TTM Avg
-144.24%
3Y Avg
-609.23%
5Y Avg
-406.15%
Market Cap
$1.51B
Operating Margin
31.49%
TTM Avg
29.35%
3Y Avg
-34.88%
5Y Avg
-5.38%
Market Cap
$1.50B
Operating Margin
0.09%
TTM Avg
-3.29%
3Y Avg
-12.30%
5Y Avg
-11595.24%
Market Cap
$1.59B
Operating Margin
-134.48%
TTM Avg
-159.75%
3Y Avg
-419.83%
5Y Avg
-335.87%
Market Cap
$1.47B
Operating Margin
13.07%
TTM Avg
10.79%
3Y Avg
8.54%
5Y Avg
8.59%
Market Cap
$1.61B
Operating Margin
-1166.77%
TTM Avg
-923.17%
3Y Avg
-941.56%
5Y Avg
-673.55%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Innoviva, Inc. (INVA) | $1.54B | 36.66% | 19.59% | 39.82% | 43.34% |
| Syndax Pharmaceuticals, Inc. (SNDX)vs › | $1.53B | -158.45% | -796.44% | -398.22% | -1047.05% |
| Stoke Therapeutics, Inc. (STOK)vs › | $1.55B | -11.16% | -144.24% | -609.23% | -406.15% |
| Nutex Health, Inc. (NUTX)vs › | $1.51B | 31.49% | 29.35% | -34.88% | -5.38% |
| Eton Pharmaceuticals, Inc. (ETON)vs › | $1.50B | 0.09% | -3.29% | -12.30% | -11595.24% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.59B | -134.48% | -159.75% | -419.83% | -335.87% |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 4.73% | 0.51% | -0.21% | 1.84% |
| Phibro Animal Health Corporation (PAHC)vs › | $1.47B | 13.07% | 10.79% | 8.54% | 8.59% |
| uniQure N.V. (QURE)vs › | $1.61B | -1166.77% | -923.17% | -941.56% | -673.55% |
| Rapport Therapeutics, Inc. Common Stock (RAPP)vs › | $1.47B | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
73.1%
Operating Margin
36.7%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 42.52% |
| 2026-03-31 | 38.94% |
| 2025-12-31 | 33.03% |
| 2025-09-30 | 32.08% |
| 2025-06-30 | -48.61% |
| 2025-03-31 | -46.74% |
| 2024-12-31 | 46.99% |
| 2024-09-30 | 55.58% |
| 2024-06-30 | 52.91% |
| 2024-03-31 | 33.30% |
| 2023-12-31 | 43.72% |
| 2023-09-30 | 36.16% |
| 2023-06-30 | 22.83% |
| 2023-03-31 | 27.64% |
| 2022-12-31 | 46.88% |
| 2022-09-30 | 18.31% |
| 2022-06-30 | 76.28% |
| 2022-03-31 | 86.31% |
| 2021-12-31 | 97.07% |
| 2021-09-30 | 96.62% |
| 2021-06-30 | 95.77% |
| 2021-03-31 | 92.94% |
| 2020-12-31 | 93.71% |
| 2020-09-30 | 95.19% |
| 2020-06-30 | 96.00% |
| 2020-03-31 | 96.74% |
| 2019-12-31 | 96.93% |
| 2019-09-30 | 92.45% |
| 2019-06-30 | 93.22% |
| 2019-03-31 | 94.54% |
| 2018-12-31 | 96.70% |
| 2018-09-30 | 93.48% |
| 2018-06-30 | 93.42% |
| 2018-03-31 | 77.69% |
| 2017-12-31 | 95.53% |
| 2017-09-30 | 82.28% |
| 2017-06-30 | 81.67% |
| 2017-03-31 | 72.47% |
| 2016-12-31 | 86.35% |
| 2016-09-30 | 83.82% |
| 2016-06-30 | 79.69% |
| 2016-03-31 | 72.52% |
| 2015-12-31 | 75.73% |
| 2015-09-30 | 62.19% |
| 2015-06-30 | 47.94% |
| 2015-03-31 | 10.80% |
| 2014-12-31 | 1.79% |
| 2014-09-30 | -955.16% |
| 2014-06-30 | -1048.61% |
| 2014-03-31 | -8923.03% |
| 2013-12-31 | -521.59% |
| 2013-09-30 | -1755.58% |
| 2013-06-30 | -519.82% |
| 2013-03-31 | -2484.15% |
| 2012-12-31 | -517.07% |
| 2012-09-30 | -2332.17% |
| 2012-06-30 | -2497.13% |
| 2012-03-31 | 67.70% |
| 2011-12-31 | -663.47% |
| 2011-09-30 | -454.08% |
| 2011-06-30 | -370.28% |
| 2011-03-31 | -336.47% |
| 2010-12-31 | -258.33% |
| 2010-09-30 | -374.29% |
| 2010-06-30 | -310.22% |
| 2010-03-31 | -369.50% |
| 2009-12-31 | -508.48% |
| 2009-09-30 | -382.25% |
| 2009-06-30 | -388.73% |
| 2009-03-31 | -192.25% |
| 2008-12-31 | -169.08% |
| 2008-09-30 | -343.72% |
| 2008-06-30 | -487.01% |
| 2008-03-31 | -536.76% |
| 2007-12-31 | -601.17% |
| 2007-09-30 | -613.11% |
| 2007-06-30 | -899.23% |
| 2007-03-31 | -968.10% |
| 2006-12-31 | -836.19% |
| 2006-09-30 | -750.31% |
| 2006-06-30 | -926.46% |
| 2006-03-31 | -1203.12% |
| 2005-12-31 | -1299.94% |
| 2005-09-30 | -1309.95% |
| 2005-06-30 | -1139.41% |
| 2005-03-31 | -1199.71% |
| 2004-12-31 | -1013.94% |
| 2004-09-30 | -884.38% |
| 2004-06-30 | -1747.03% |
